Contents

Recent Patents on Anti-Cancer Drug Discovery, Volume 1 - Number 3

c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer

, 1(3): 305 - 326

Sam Robson, Stella Pelengaris and Michael Khan


DOI: 10.2174/157489206778776934




Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents

, 1(3): 327 - 346

Stephen J. Ralph, Pauline Low, Langfeng Dong, Alfons Lawen and Jiri Neuzil


DOI: 10.2174/157489206778776952




Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone

, 1(3): 347 - 355

Shinya Kimura


DOI: 10.2174/157489206778776907




Inhibition of Cyclin-Dependent Kinases - A Review of the Recent Patent Literature

, 1(3): 357 - 367

Andrea D. Basso and Ronald J. Doll


DOI: 10.2174/157489206778776916




Regulation of Cell Proliferation and Apoptosis by Bioactive Lipid Mediators

, 1(3): 369 - 382

Joan Claria


DOI: 10.2174/157489206778776961




Last Generation of Amino-Bisphosphonates (N-BPs) and Cancer Angiogenesis: A New Role for These Drugs?

, 1(3): 383 - 396

Daniele Santini, Gaia Schiavon, Silvia Angeletti, Bruno Vincenzi, Simona Gasparro, Claudia Grilli, Annalisa La Cesa, Vladimir Virzi, Valentina Leoni, Alfredo Budillon, Santolo R. Addeo, Michele Caraglia, Giordano Dicuonzo and Giuseppe Tonini


DOI: 10.2174/157489206778776989




Bortezomib in the Treatment of Cancer

, 1(3): 397 - 403

Aldo M. Roccaro, Angelo Vacca and Domenico Ribatti


DOI: 10.2174/157489206778776925




Patent Annotations

, 1(3): 405 - 408

Bentham Science Publishers


DOI: 10.2174/157489206778776970




Patent Selections

, 1(3): 409 - 411

Bentham Science Publishers


DOI: 10.2174/157489206778776943




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science